GenomePT
February 25, 2026Porto NS
February 25, 2026
In2Genome
1. PROJECT NAME: In2Genome – An integrative approach to the diagnosis of genetic diseases
2. PROJECT ID: CENTRO-01-0247-FEDER-017800
3. MAIN GOAL: Speeding up the diagnosis of genetic diseases
4. REGION: Center (of Portugal)
5. BENEFICIARY ENTITIES: CBRA Genomics, S.A. | Biocant – Associação de Transferência de Tecnologia | Centro Hospital e Universitário de Coimbra, E.P.E.
6. APPROVAL DATE: May 2, 2017
7. START DATE: July 1, 2017
8. END DATE: 30-06-2020
9. TOTAL ELIGIBLE COSTS:
| Entity | Investment | Total eligible costs | |||||
| CBRA GENOMICS, S.A. | 398 583,91 EUR | 398 583,91 EUR | |||||
| BIOCANT – ASSOCIAÇÃO DE TRANSFERÊNCIA DE TECNOLOGIA | 289 825,32 EUR | 289 825,32 EUR | |||||
| CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA, E.P.E. | 293 962,66 EUR | 284 586,99 EUR | |||||
| TOTAL | 982 371,89 EUR | 972 996,22 EUR |
10. FINANCIAL SUPPORT FROM THE EUROPEAN UNION (FEDER):
| Entity | Financial support | ||||
| CBRA GENOMICS, S.A. | 285 226,46 EUR | ||||
| BIOCANT – ASSOCIAÇÃO DE TRANSFERÊNCIA DE TECNOLOGIA | 217 368,99 EUR | ||||
| CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA, E.P.E. | 213 440,24 EUR | ||||
| TOTAL | 716 035,69 EUR |
11. OBJECTIVES, ACTIVITIES, AND EXPECTED/ACHIEVED RESULTS
This project aims to develop and implement new tools on the ExomeLoupe platform for variant analysis in
individuals with rare diseases.
